Mesothelin antibody protein fusions and methods of use

    公开(公告)号:US08435494B2

    公开(公告)日:2013-05-07

    申请号:US13107624

    申请日:2011-05-13

    IPC分类号: A61K49/00 A61K39/00 A61K39/38

    摘要: The invention relates to fusion proteins comprising a stress protein fused with an engineered antibody or fragment that binds to mesothelin, or a stress protein fused with a biotin-binding protein in combination with a biotinylated engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising a stress protein fused with an antibody binding protein in combination with an engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising an engineered antibody or fragment that binds specifically to mesothelin fused in frame with a biotin binding protein. The invention also provides fusion proteins comprising an engineered antibody or fragment, that binds to mesothelin, fused with an antibody binding protein. The invention also relates to methods of using fusion proteins of the invention to induce an immune response to mesothelin and to treat disease.

    Mesothelin antibody protein fusions and methods of use
    6.
    发明授权
    Mesothelin antibody protein fusions and methods of use 有权
    间皮素抗体蛋白融合和使用方法

    公开(公告)号:US07943133B2

    公开(公告)日:2011-05-17

    申请号:US12291104

    申请日:2008-11-06

    IPC分类号: A61K39/00

    摘要: The invention relates to fusion proteins comprising a stress protein fused with an engineered antibody or fragment that binds to mesothelin, or a stress protein fused with a biotin-binding protein in combination with a biotinylated engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising a stress protein fused with an antibody binding protein in combination with an engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising an engineered antibody or fragment that binds specifically to mesothelin fused in frame with a biotin binding protein. The invention also provides fusion proteins comprising an engineered antibody or fragment, that binds to mesothelin, fused with an antibody binding protein. The invention also relates to methods of using fusion proteins of the invention to induce an immune response to mesothelin and to treat disease.

    摘要翻译: 本发明涉及包含与工程化抗体或与间皮素结合的片段融合的应激蛋白或与生物素结合蛋白融合的应激蛋白与融合了间皮素的生物素化工程化抗体或片段的融合蛋白。 本发明还涉及包含与抗体结合蛋白融合的应激蛋白与融合于间皮素的工程化抗体或片段组合的融合蛋白。 本发明还涉及包含与生物素结合蛋白框架融合的间皮素的特异性结合的工程化抗体或片段的融合蛋白。 本发明还提供融合蛋白,其包含与抗体结合蛋白融合的间皮素的工程化抗体或片段。 本发明还涉及使用本发明的融合蛋白诱导对间皮素的免疫应答并治疗疾病的方法。

    Engineered antibody-stress protein fusions
    7.
    发明授权
    Engineered antibody-stress protein fusions 有权
    工程抗体 - 应激蛋白融合

    公开(公告)号:US07749501B2

    公开(公告)日:2010-07-06

    申请号:US12185631

    申请日:2008-08-04

    IPC分类号: A61K39/00

    摘要: Provided are fusion polypeptides comprising an engineered antibody and a stress protein that bind to antigens with high affinity, are highly immunogenic, exhibit MHC class I priming and are able to be produced in non-mammalian cells, such as E. coli.

    摘要翻译: 提供了包含工程化抗体和与高亲和力结合抗原的应激蛋白的融合多肽,是高度免疫原性的,表现出MHC I类引发,并能够在非哺乳动物细胞如大肠杆菌中产生。

    Mesothelin antibody protein fusions and methods of use
    8.
    发明申请
    Mesothelin antibody protein fusions and methods of use 有权
    间皮素抗体蛋白融合和使用方法

    公开(公告)号:US20090155269A1

    公开(公告)日:2009-06-18

    申请号:US12291104

    申请日:2008-11-06

    摘要: The invention relates to fusion proteins comprising a stress protein fused with an engineered antibody or fragment that binds to mesothelin, or a stress protein fused with a biotin-binding protein in combination with a biotinylated engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising a stress protein fused with an antibody binding protein in combination with an engineered antibody or fragment that binds to mesothelin. The invention also relates to fusion proteins comprising an engineered antibody or fragment that binds specifically to mesothelin fused in frame with a biotin binding protein. The invention also provides fusion proteins comprising an engineered antibody or fragment, that binds to mesothelin, fused with an antibody binding protein. The invention also relates to methods of using fusion proteins of the invention to induce an immune response to mesothelin and to treat disease.

    摘要翻译: 本发明涉及包含与工程化抗体或与间皮素结合的片段融合的应激蛋白或与生物素结合蛋白融合的应激蛋白与融合了间皮素的生物素化工程化抗体或片段的融合蛋白。 本发明还涉及包含与抗体结合蛋白融合的应激蛋白与融合于间皮素的工程化抗体或片段组合的融合蛋白。 本发明还涉及包含与生物素结合蛋白框架融合的间皮素的特异性结合的工程化抗体或片段的融合蛋白。 本发明还提供融合蛋白,其包含与抗体结合蛋白融合的间皮素的工程化抗体或片段。 本发明还涉及使用本发明的融合蛋白诱导对间皮素的免疫应答并治疗疾病的方法。